Clinical Trials Logo

Chronic Pain clinical trials

View clinical trials related to Chronic Pain.

Filter by:
  • Suspended  
  • Page 1 ·  Next »

NCT ID: NCT05700331 Suspended - Clinical trials for Chronic Widespread Pain

Fecal Microbiota Transplantation for Patients With Chronic Widespread Pain

Start date: January 2025
Phase: N/A
Study type: Interventional

This study aims to explore the effect of Fecal Microbiota Transplantation (FMT) on the clinical symptomatology in Chronic Widespread Pain (CWP), to assess the acceptability, tolerability, and safety of FMT in patients with CWP, as well as explore the effect of FMT on the gut microbiome diversity in CWP. The investigators hypothesize that fecal microbiota transplantation will reduce pain intensity in patients with CWP, is acceptable, safe, and tolerable in patients with CWP, and will achieve change of gut microbiome diversity after FMT treatment.

NCT ID: NCT05482152 Suspended - Pain, Chronic Clinical Trials

Nurse-led Pain Education Clinical Trial in Chronic Pain Patients

Start date: January 14, 2022
Phase: N/A
Study type: Interventional

Chronic pain is a multidimensional problem that consequently requires interventions on multiple levels. Pain education by physicians is one of the interventions that shows promising results in patient reported outcomes. It is however unclear if nurse-led chronic pain education could be equally effective on pain attitude and behavior in chronic pain patients. The aim of this clinical trial is to investigate the effects of a nurse-led consultation with chronic pain patients on pain attitude and patient satisfaction compared with regular care without nurse specialist intervention.

NCT ID: NCT05394545 Suspended - Depression Clinical Trials

Phase II Trial of Nu-V3 Non-Invasive Nerve Stimulation Device for Chronic Pain, Anxiety, Depression, Sleeplessness

Nu-V3P2RCT
Start date: March 20, 2024
Phase: N/A
Study type: Interventional

This Nu-V3 clinical study is a randomized, phase II, open-label study evaluating the Nu-V3 cranial nerve stimulation treatment device in patients with chronic pain, anxiety, depression, and/or sleeplessness.

NCT ID: NCT05259878 Suspended - Chronic Pain Clinical Trials

Adverse Childhood Events Chronic Pain

Start date: January 1, 2021
Phase:
Study type: Observational

There is data to suggest that early childhood physical, emotional and sexual trauma could contribute to the development of chronic pain later in life, but this has not been studied in the Canadian Forces. The investigator will examine the relationship between adverse childhood events (ACE) and patient reported pain and function conducted within the CAF

NCT ID: NCT05259865 Suspended - Chronic Pain Clinical Trials

Pharmacogenetic Testing and Chronic Pain

Start date: September 21, 2025
Phase:
Study type: Observational

Understanding the impact of genetics could aid rational, precision drug choices. In the current study, investigators will focus on whether genetic analysis of drug processing using the Inagene platform could predict efficacy and side effect profile in patients prescribed medication for pain.

NCT ID: NCT04896827 Suspended - Chronic Pain Clinical Trials

DNIC Using Deep Learning and Artificial Intelligence

Start date: April 5, 2022
Phase:
Study type: Observational

Chronic pain (CP) is disabling for people triggering important costs for society. A deficit of diffuse noxious inhibitory controls (DNIC) is one of the CP mechanisms. DNICs are evaluated in research setting using a CPM protocol (conditioned pain modulation). There is a lack of reference values on the effectiveness of DNICs. Wider research on DNIC will help to understand CP and to develop a clinical screening test evaluating DNICs. This study aims more specifically to determine whether it is possible to develop a facial recognition system to automate pain measurement and the effectiveness of pain control mechanisms.

NCT ID: NCT04876859 Suspended - Chronic Pain Clinical Trials

Comparative Study Between Steroid Plus Anesthetic Block and CRF in Participants With Hip Osteoarthritis

Start date: June 8, 2021
Phase: Phase 3
Study type: Interventional

This will be a prospective, multi-center, double-blinded, randomized study designed to compare the efficacy of Conventional Radiofrequency (CRF) and the anesthetic block of the anterior sensory branches to the hip to control pain and improve function related to hip osteoarthritis.

NCT ID: NCT04681027 Suspended - Chronic Pain Clinical Trials

Safety, Tolerability, Effectiveness, and Pharmacokinetic Data in Opioid-experienced Children

Start date: March 11, 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study was to assess the safety and pharmacokinetics (single- and multiple-dose) of oxymorphone ER for the relief of moderate to severe pain in pediatric participants ages 7 - ≤17 years old requiring a continuous, around-the-clock (ATC) opioid treatment for an extended period.

NCT ID: NCT04534101 Suspended - Chronic Pain Clinical Trials

Medical Mindfulness: Virtual Reality Mindfulness Therapy for Anxiety and Pain Management in Patients With Acute and Chronic Pain

VR Mindfulness
Start date: July 10, 2018
Phase:
Study type: Observational

Adults and children undergoing medical care (inpatient or outpatient) often experience pain and anxiety either as a result of their medical condition or a side effect of medical procedures. The purpose of this study is to create a registry of patients using virtual reality (VR) mindfulness therapy through different aspects of their medical care to determine if VR mindfulness therapy is more effective than the standard of care (i.e., no technology based distraction) for treating or preventing anxiety and pain in adults and children suffering from chronic pain, GI conditions where pain is a common symptom, or undergoing any painful medical procedure (i.e. IV access, blood draws, endoscopy, surgery). The anticipated primary outcome will be reduction of pain and anxiety for both acute and chronic pain.

NCT ID: NCT04306939 Suspended - Clinical trials for Rheumatoid Arthritis

Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study

GREAT1
Start date: November 1, 2014
Phase:
Study type: Observational

This is a prospective, descriptive, observational research study designed to observe and document the clinical practice by domain experts, and how the knowledge of new findings that are published in the medical literature affect clinical decision making. The study will evaluate risk factors and co-variants, including genetic variants that are associated with disease progression such as pain, inflammation, organ dysfunction, disability and quality of life.